Characterisation of a Novel Bioactive Strontium Bioglass-Based Endodontic Sealer

New hard tissue formation helps create a more stable seal in endodontic treatment. To achieve this, a novel class of endodontic sealers containing the pro-osteogenic element, strontium (within a BG), embedded in a polydimethylsiloxane matrix (Sr-PDMS) was produced. The properties of this sealer were compared with a commercially available bioactive endodontic sealer, Guttaflow Bioseal (GFBS). Glass was prepared via the melt quench method and incorporated into the GFBS matrix. Its physical properties were tested against the International Organisation for Standardisation (ISO) 6876. For biocompatibility assessment, dose–response proliferation of OCCM-30 cells was quantified by measuring DNA levels in varying concentrations of exogenous calcium and strontium, in culture media conditioned with the novel BG powder, and in sealer discs of the GFBS and novel Sr-PDMS. Two-way ANOVA followed by one-way ANOVA and the Bonferroni post hoc test were applied to the cell viability data. Both the GFBS and novel Sr-PDMS sealants demonstrated physical properties that met ISO 6876, but Sr-PDMS displayed greater radiopacity (p < 0.05), lower solubility, and increased setting time. Both sealants released ions into the immersion solution, with the additional release of Sr from the novel sealer. GFBS displayed evidence of apatite formation. As expected, high concentrations of BG-conditioned media were cytotoxic, but the levels released by the BG in the Sr-PDMS were not cytotoxic with 1:000 dilution and resulted in significantly increased (p < 0.01) cell proliferation compared to the control group.